SHZ · 002001.SZ
Zhejiang NHU Company Ltd.
CN¥25.68+CN¥0.24 (+0.94%)
Zhejiang NHU Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.1% below the high.
Loading market information…
SHH · 600216.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:14 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Zhejiang Medicine Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 42.84% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Zhejiang Medicine Co., Ltd.’s forward annual dividend is CN¥0.28 per share, paid annual. The forward yield is 2.64% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Zhejiang Medicine Co., Ltd.’s next earnings report is currently expected on Apr 28, 2027, with estimated earnings per share of CN¥0.16. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Zhejiang Medicine Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Zhejiang Medicine Co., Ltd. is a Chinese enterprise specializing in the manufacturing and distribution of both nutritional supplements and pharmaceutical goods. Its life nutrition portfolio encompasses a wide array of offerings, such as synthetic and natural vitamin E, vitamin A, vitamin H, vitamin D3, coenzyme Q10, carotene, cantharidin, lutein, and lycopene, alongside various other vitamin compounds. Beyond nutrition, the company is a significant supplier in the pharmaceutical sector. This includes the production of active pharmaceutical ingredients and raw materials like specialized antibiotics for drug-resistant strains, anti-malarial compounds, and quinolone derivatives. Furthermore, it develops and markets finished pharmaceutical products, notably sugar-based medications and hormonal preparations. Established in 1997, Zhejiang Medicine Co., Ltd. maintains its headquarters in Shaoxing, China.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:29 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| Q2 2025 | Aug 25, 2025 | CN¥0.27-20.59% vs estimate | CN¥2.07B+0.07% vs estimate |
|---|
| Q1 2025 | Apr 24, 2025 | CN¥0.43+22.86% vs estimate | CN¥2.26B+0.22% vs estimate |
|---|
| Q1 2025 | Apr 23, 2025 | CN¥0.32-8.57% vs estimate | CN¥2.26B |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥25.68+CN¥0.24 (+0.94%)
Zhejiang NHU Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 36.1% below the high.
CN¥15.63+CN¥0.58 (+3.85%)
Zhejiang Jiuzhou Pharmaceutical Co., Ltd’s quoted price sits in the lower half of its reported 52-week range, 29.75% below the high.
CN¥5.59-CN¥0.21 (-3.62%)
Zhejiang Hisoar Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 38.5% below the high.
CN¥8.91+CN¥0.05 (+0.56%)
Zhejiang Xianju Pharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 11.34% below the high.
CN¥4.57+CN¥0.03 (+0.66%)
North China Pharmaceutical Company Ltd.’s quoted price sits in the lower half of its reported 52-week range, 33.77% below the high.
CN¥19.92-CN¥0.13 (-0.65%)
Zhejiang Tianyu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 28.35% below the high.
CN¥11.92-CN¥0.12 (-1.0%)
Zhejiang Garden Biopharmaceutical Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.15% below the high.
CN¥4.36+CN¥0.03 (+0.69%)
Northeast Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 26.48% below the high.
